SOPHiA GENETICS Reviews

StackAI is an enterprise AI automation platform built to help organizations create end-to-end internal tools and processes with AI agents. Unlike point solutions or one-off chatbots, StackAI provides a single platform where enterprises can design, deploy, and govern AI workflows in a secure, compliant, and fully controlled environment. Using its visual workflow builder, teams can map entire processes — from data intake and enrichment to decision-making, reporting, and audit trails. Enterprise knowledge bases such as SharePoint, Confluence, Notion, Google Drive, and internal databases can be connected directly, with features for version control, citations, and permissioning to keep information reliable and protected. AI agents can be deployed in multiple ways: as a chat assistant embedded in daily workflows, an advanced form for structured document-heavy tasks, or an API endpoint connected into existing tools. StackAI integrates natively with Slack, Teams, Salesforce, HubSpot, ServiceNow, Airtable, and more. Security and compliance are embedded at every layer. The platform supports SSO (Okta, Azure AD, Google), role-based access control, audit logs, data residency, and PII masking. Enterprises can monitor usage, apply cost controls, and test workflows with guardrails and evaluations before production. StackAI also offers flexible model routing, enabling teams to choose between OpenAI, Anthropic, Google, or local LLMs, with advanced settings to fine-tune parameters and ensure consistent, accurate outputs. A growing template library speeds deployment with pre-built solutions for Contract Analysis, Support Desk Automation, RFP Response, Investment Memo Generation, and InfoSec Questionnaires. By replacing fragmented processes with secure, AI-driven workflows, StackAI helps enterprises cut manual work, accelerate decision-making, and empower non-technical teams to build automation that scales across the organization.

RXNT has spent over 25 years building cloud-based healthcare software designed for ambulatory practices and medical organizations of all sizes and specialties. Our innovative, AI-powered, and data-backed software solutions help practices grow, improve clinical efficiency, and streamline business operations—whether you're a solo provider, large healthcare organization, or billing services company. With over 60,000 medical professionals across all 50 U.S. states relying on RXNT, our fully-integrated, ONC-certified software system includes Electronic Health Records (EHR), Physician Practice Management (PPMS), Medical Billing and Revenue Cycle Management (RCM), E-Prescribing (eRx), Scheduling, Patient Portal, mobile applications, and more. Every product works seamlessly as one system or can be used standalone, giving you flexibility to choose what works best for your practice. Our SaaS-based Full Suite software solution integrates every area of RXNT through a secure, centralized database, enabling real-time data flow across clinical and administrative functions. Whether you're modernizing your medical practice or scaling your healthcare business, RXNT delivers all-in-one technology to help you succeed. So far, users have transmitted over 125 million prescriptions and processed more than $7 billion in insurance claims. Built for usability and accessibility, RXNT’s cloud-based software is available 24/7 from any device and includes mobile apps for iOS and Android. Simple, transparent pricing means no hidden fees, and every plan includes free implementation & training periods, data migration, storage, software updates, and U.S.-based customer service.

Pharmaceutical firms need a wealth of genomic information to successfully execute precision medicine strategies; however, they often utilize only a fraction—around 10%—of the total data at their disposal for decision-making. Genomenon offers an extensive database to counter this limitation. Their Prodigy™ Patient Landscapes deliver a cost-effective and efficient approach for conducting natural history research, which is crucial for developing treatments for rare conditions by expanding the understanding of both past and future health data. Employing a sophisticated AI-driven process, Genomenon meticulously analyzes each patient referenced in the medical literature much faster than traditional methods. It is essential to capture all pertinent insights by examining every genomic biomarker highlighted in scholarly articles. Each scientific assertion is backed by solid evidence sourced from medical literature, enabling researchers to identify all genetic factors and pinpoint variants classified as pathogenic according to ACMG clinical criteria, thus streamlining the creation of targeted therapies. By adopting this thorough strategy, pharmaceutical companies can significantly boost their research efficiency and, in turn, enhance patient outcomes. This innovative model not only fosters advancements in drug development but also contributes to a deeper understanding of genetic influences on health.